When: Confirmed golden cross (50 SMA crossing above 200 SMA) on rising volume

Then: Add to position or initiate new position

When: Fed pivot credible - Polymarket odds of cuts improve OR 30-year yields decline below 4.5%

Then: Add to position

When: 2 consecutive quarters of 60%+ YoY revenue growth on tougher comps

Then: Upgrade to active accumulation - validates deceleration isn't cliff-like

When: Confirmed golden cross AND either macro easing (yields declining) OR successful test of $150-160 support with momentum recovery

Then: Upgrade to Overweight

HOLD with 15-25% trim into $179-187 resistance zone; scale in at $150-160 support or await golden cross plus Fed pivot

• 74x forward P/E on $2.31 forward EPS (98% earnings growth) prices perfection not scarcity, vulnerable to 32% compression if execution wobbles
• 1.563 beta in 19-year-high yield environment with 85% probability of zero Fed cuts in 2026 — equity multiple compresses even if revenue is contractual
• Trim 15-25% into $179-187 resistance zone anchored to Aug 13 swing high ($179.01), Aug 14 intraday high ($180.18), below Bollinger upper band ($197.01)
• Entry zone of $150-160 anchored to 200 SMA ($151.87), post-gap support ($162.66), and 10 EMA ($166.91); 2× ATR pullback is normal in high-beta names
• $1.2B TTM SBC is real economic cost regardless of stabilizing share count; VWMA at $158.30 with price 8.3% above indicates SBC-related volume
• Golden cross is a lagging indicator; positioning before it via pullback to 200 SMA zone is preferable to buying after confirmation
• Fundamentals are elite: 54.9% net margin, 62% FCF margin, $9.4B fortress balance sheet, 38.1% ROE, Q2'26 revenue $1.9355B (up 93% YoY)
• Year-over-year comparisons get harder in late 2026 and brutal in 2027 as comps normalize
• Conservative risk: missing next leg up if consolidation breaks higher; mitigated by keeping core exposure while reducing overextended position size

→ vs aggressive: 74x P/E is 'scarcity pricing' — actually prices perfection requiring 98% earnings growth; 10% execution wobble or tax normalization to 21% compresses multiple immediately

→ vs aggressive: Macro dismissal is dangerous — equity valuation is present value of future cash flows; every basis point increase in 30-year Treasury directly compresses PV; PLTR's equity multiple absolutely cares about rates even if revenue doesn't

→ vs aggressive: Trim recommendation of 15-25% into $179-187 is dismissed as 'performance anxiety' but is actually disciplined rebalancing anchored to technical resistance, not a sale of conviction

→ vs aggressive: Waiting for $150-160 is not 'anchoring to last quarter' — it's anchored to structural support levels (200 SMA, post-gap support, 10 EMA) where buyers have historically stepped in

→ vs aggressive: SBC overhang is not gone — $1.2B TTM is real economic cost; VWMA analysis shows SBC-driven volume in the rally; dilution resumes if growth slows or cash deployed for acquisition

→ vs aggressive: Golden cross as entry trigger is paying full price for insurance in an already-moved name; it's a lagging confirmation signal, not a leading entry signal

HOLD with refined implementation

• Current consolidation is a $9 range ($170-$180) over 9 sessions representing 5.5% digestion after the 29.5% Aug 4 gap-up, not a launchpad
• Trim 10-15% (lighter than conservative's 15-25%) into $183-187 zone (between Aug 14 intraday high and 2x ATR resistance at $187.18) rather than $179-187 to avoid trimming at breakout level
• Widen stop loss from $163 to $155.90 (2x ATR of $7.82) to avoid being clipped on noise while remaining below 200 SMA structural support
• Use options collar (sell upside calls to finance downside puts) to hedge macro risk rather than reducing position, given elevated IV and 1.563 beta
• Q2 revenue of $1.94B (92.8% YoY) with 54.9% net margin and 62% FCF margin supports HOLD, but growth rate will mathematically decay as comps increase through Q2'27
• Golden cross will confirm over coming weeks but is a confirmation tool, not a trade trigger — should already be positioned before it prints
• Share dilution has stabilized at 2.569B vs 2.563B year ago, making SBC of $1.2B TTM a moderating (not accelerating) drag; forward EPS of $2.31 vs trailing $1.17 implies ~98% earnings growth
• Single position should not exceed 5-7% of diversified portfolio regardless of fundamentals given high-beta/high-IV profile
• Mildly bullish sentiment at 6.2/10 with medium confidence reflects broadly accepted bull case but real valuation anxiety — smart money is selective, not all-in
• New entries in $150-160 zone should use momentum triggers (RSI reset toward 50 on 200 SMA test, or MACD pullback that doesn't break structure) rather than buying blindly

→ vs aggressive: Dismissive of macro risk with 1.563 beta — high-multiple names get hit harder in hawkish Fed/rising yield environments; conflated government cash flow insulation with equity multiple protection; treating one explosive day as structural regime change when price has chopped $9 for 9 sessions with buyers refusing to push through $180

→ vs conservative: Mechanically assumes pullback to $150-160 is inevitable — RSI 65.74, rising 10 EMA, positive expanding MACD, and intact Aug 4 gap suggest consolidation can resolve upward without giving_entry; trim at $179-187 caps upside right at breakout level and forces either missing the move or chasing re-entry at higher prices